Published in
Tumori, 2014November-December, 2014
DOI: 10.1700/1778.19296
SAGE Publications, Tumori Journal, 6(100), p. e282-e285
DOI: 10.1177/1778.19296
Links
Tools
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
Journal article published in 2014 by
Roberto Iacovelli,
Filippo de Braud,
Elena Verzoni,
Paolo Grassi,
Alessio Farcomeni,
F. De Braud,
Giuseppe Procopio 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 